Aurogra 100 mg

Medically Reviewed by Henry V

 Dr. Henry V

Qualification: PharmD

Experience: 14+ Years in Clinical Practice Expert in reviewing pharmaceutical and health-related content for medical accuracy. View more

What Is Aurogra 100 mg?

Aurogra 100 mg is a prescription medication containing sildenafil citrate 100 mg as its active pharmaceutical ingredient, manufactured by Aurochem Laboratories. Sildenafil citrate is the same molecule used in the originator brand Viagra, and Aurogra is classified pharmacologically as a generic formulation of it. As a prescription medication, it is intended to be dispensed and used under medical supervision, not selected or dosed by the patient independently.

Clinically, sildenafil citrate belongs to the phosphodiesterase type 5 (PDE5) inhibitor drug class, indicated for the treatment of erectile dysfunction in men. Its mechanism of action is well characterized: sexual stimulation triggers local release of nitric oxide in the corpus cavernosum, which activates guanylate cyclase and raises levels of cyclic guanosine monophosphate (cGMP). Elevated cGMP relaxes cavernosal smooth muscle and increases arterial inflow, producing an erection. PDE5 is the enzyme responsible for degrading cGMP; by selectively inhibiting PDE5, sildenafil prolongs cGMP activity and enhances the erectile response to sexual stimulation. As with all PDE5 inhibitors, sildenafil has no effect in the absence of sexual stimulation and does not itself initiate arousal.

Aurogra 100 mg is indicated only after a physician has ruled out contraindications and assessed the underlying cause of a patient's ED — which may be vascular, neurogenic, endocrine (e.g., low testosterone, diabetes-related), psychogenic, or mixed in etiology. Being a generic prescription medication, it is typically lower in cost than the branded equivalent, though patients should be aware that manufacturing standards and regulatory oversight for generic prescription medications can differ by country of origin and distribution channel.

How to Take Aurogra 100 mg

Aurogra 100 mg should only be taken according to the dosing schedule set by the prescribing physician, using the exact strength and frequency indicated on the prescription. General clinical guidance for this class of oral PDE5 inhibitor tablet includes:

• Single dose, as prescribed. The tablet is generally taken as one oral dose approximately 30–60 minutes before anticipated sexual activity, not on a fixed daily schedule unless a physician has specifically prescribed a different regimen.
• Maximum one dose per 24-hour period. Sildenafil citrate is not intended for repeat dosing within a day; exceeding the prescribed frequency increases the risk of adverse effects without added benefit.
• Food interactions. Absorption may be delayed by a high-fat meal taken shortly beforehand, which can reduce or slow the onset of clinical effect.
• Alcohol. Concurrent heavy alcohol use can potentiate hypotensive effects (low blood pressure) and is generally discouraged with this medication.
• No dose adjustment without medical guidance. Patients should not split, crush, double up on, or combine tablets with other ED medications or supplements outside of what a physician has prescribed.
• Sexual stimulation remains required. As with all PDE5 inhibitors, the medication facilitates but does not independently trigger the erectile response.

Because sildenafil citrate has clinically significant drug interactions — most critically with nitrate medications used for angina, and with certain antihypertensives and alpha-blockers — a physician's assessment of a patient's full medication list and cardiovascular status is a mandatory prerequisite before this prescription medication is dispensed, particularly given that sexual activity itself imposes cardiac exertion.

How Long Does Aurogra 100mg Last?

Pharmacokinetically, oral sildenafil citrate reaches peak plasma concentration approximately 60 minutes after administration, with clinical onset typically observed within 30–60 minutes. The therapeutic window during which a patient may respond to sexual stimulation generally extends to 4–6 hours post-dose, though the drug's elimination half-life and clinical duration can vary based on individual patient factors — age, hepatic and renal function, concomitant medications, and metabolic rate.

Patients should understand this window represents a period of pharmacological responsiveness to stimulation, not a continuous physiological state. Prescribers may adjust expectations or dosing for patients with hepatic or renal impairment, in whom drug clearance is slower and clinical effect may persist longer, warranting closer monitoring.

Side Effects of Aurogra 100 mg

As with any prescription medication in the PDE5 inhibitor class, Aurogra 100 carries a defined adverse effect profile ranging from common and self-limited to rare but medically serious.

Commonly reported adverse effects:

• Headache
• Flushing
• Nasal congestion
• Dyspepsia (indigestion)
• Dizziness
• Transient visual disturbances (e.g., blue-tinged vision, increased light sensitivity)

Precautions and Warnings for Aurogra 100mg (Sildenafil Citrate)